{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:05:55Z","timestamp":1768593955735,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients diagnosed on endometrial biopsy with complex endometrial hyperplasia with atypia (CEHA).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective study of 86 cases diagnosed with endometrial hyperplasia with atypia on the initial endometrial biopsy in a tertiary university teaching hospital between 2010 and 2015 was carried out. The MRI accuracy in predicting malignant changes and influence the clinical management was compared among women who had either pelvic MRI, transvaginal ultrasound (TVUS), or no additional imagistic studies.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>MRI was performed in 24 (28%) and TVUS in 11 (13%)cases, while 51 (59%) women had no additional imagistic studies. In the group of women with no imaging studies, 26\/51 (51%) were surgically treated and 8\/26 (31%) were diagnosed with endometrial cancer (EEC) stage 1a. In the group of women who had TVUS, 5\/11 (45%) were surgically treated and none was diagnosed with EEC. In the group of women who underwent an MRI examination, 20\/24 (83%) were surgically treated. Among these, 11\/20 (55%) were diagnosed with EEC, 7 had EEC\u00a0stage 1a, and 4 had EEC stage 1b. Although MRI was able to identify malignant changes with a good sensitivity (91.7%), it had a low specificity in characterisation of malignant transformation (8%). MRI correctly identified 31% of the stage 1a and 33% of the stage 1b endometrial cancer.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In this study, we found a potential diagnostic value of MRI for identifying malignant transformation in patients with CEHA. However, pelvic MRI has a rather weak predictive value of myometrial invasion in women with CEHA and concurrent EEC. The diagnostic and therapeutic benefits of MRI assessment in patients with CEHA need further validation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12957-020-1811-5","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T17:02:50Z","timestamp":1581354170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The value of MRI in management of endometrial hyperplasia with atypia"],"prefix":"10.1186","volume":"18","author":[{"given":"Purushothaman","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2432-2616","authenticated-orcid":false,"given":"Angela","family":"Vinturache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Broadhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"1811_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491\u2013505.","journal-title":"Lancet."},{"key":"1811_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J Clin. 2011;61:212\u201336.","journal-title":"Cancer J Clin."},{"key":"1811_CR3","doi-asserted-by":"publisher","first-page":"678.e1","DOI":"10.1016\/j.ajog.2009.02.032","volume":"200","author":"SD Reed","year":"2009","unstructured":"Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009;200:678.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"1811_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1756-0500-5-279","volume":"5","author":"A Cormio","year":"2012","unstructured":"Cormio A, Guerra F, Cormio G, Pesce V, Fracasso F, Loizzi V, et al. Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. BMC Res Notes. 2012;5:279.","journal-title":"BMC Res Notes."},{"key":"1811_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000321390","volume":"72","author":"O Ozdegirmenci","year":"2011","unstructured":"Ozdegirmenci O, Kayikcioglu F, Bozkurt U, Akgul MA, Haberal A. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia. Gynecol Obstet Invest. 2011;72:10\u20134.","journal-title":"Gynecol Obstet Invest."},{"key":"1811_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","volume":"56","author":"RJ Kurman","year":"1985","unstructured":"Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients. Cancer. 1985;56:403\u201312.","journal-title":"Cancer."},{"key":"1811_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","volume":"98","author":"JV Lacey Jr","year":"2008","unstructured":"Lacey JV Jr, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, Chatterjee N, et al. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer. 2008;98:45\u201353.","journal-title":"Br J Cancer."},{"key":"1811_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0002-9378(89)90103-8","volume":"160","author":"A Ferenczy","year":"1989","unstructured":"Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol. 1989;160:126\u201331.","journal-title":"Am J Obstet Gynecol."},{"key":"1811_CR9","volume-title":"Management of endometrial hyperplasia. Green Top Guideline No. 67","author":"RCOG and British Society for Gynaecological Endoscopy","year":"2016","unstructured":"RCOG and British Society for Gynaecological Endoscopy. Management of endometrial hyperplasia. Green Top Guideline No. 67. 2016."},{"key":"1811_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.maturitas.2009.02.005","volume":"63","author":"JV Lacey Jr","year":"2009","unstructured":"Lacey JV Jr, Chia VM. Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas. 2009;63:39\u201344.","journal-title":"Maturitas."},{"key":"1811_CR11","unstructured":"Cancer Research UK. Uterine cancer incidence statistics. Uterine cancer incidence by UK region. http:\/\/www.cancerresearchuk.org (accessed April 20, 2018)."},{"key":"1811_CR12","doi-asserted-by":"publisher","first-page":"e2374","DOI":"10.7717\/peerj.2374","volume":"4","author":"JS Yuk","year":"2016","unstructured":"Yuk JS. The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study. Peer J Inc. 2016;4:e2374.","journal-title":"Peer J Inc."},{"key":"1811_CR13","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/ijc.27457","volume":"131","author":"JV Lacey","year":"2012","unstructured":"Lacey JV, Chia VM, Rush BB, Carreon DJ, Richesson DA, Ioffe OB, et al. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. Int J Cancer. 2012;131:1921\u20139.","journal-title":"Int J Cancer."},{"key":"1811_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/jcu.20049","volume":"32","author":"TJ Dubinsky","year":"2004","unstructured":"Dubinsky TJ. Value of sonography in the diagnosis of abnormal vaginal bleeding. J Clin Ultrasound. 2004;32:348\u201353.","journal-title":"J Clin Ultrasound."},{"key":"1811_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1470-2045(10)70268-0","volume":"12","author":"I Jacobs","year":"2011","unstructured":"Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12:38\u201348.","journal-title":"Lancet Oncol."},{"key":"1811_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11912-016-0506-0","volume":"18","author":"IS Haldorsen","year":"2016","unstructured":"Haldorsen IS, Salvesen HB. What is the best preoperative imaging for endometrial cancer? Curr Oncol Rep. 2016;18:25.","journal-title":"Curr Oncol Rep."},{"key":"1811_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygyno.2008.08.001","volume":"111","author":"N Bansal","year":"2008","unstructured":"Bansal N, Herzog TJ, Brunner-Brown A, Wethington SL, Cohen CJ, Burke WM, et al. The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol. 2008;111:208\u201312.","journal-title":"Gynecol Oncol."},{"key":"1811_CR18","volume-title":"Health Insurance Portability and Accountability Act of 1996","author":"HIPAA","year":"1996","unstructured":"HIPAA. In: Services BA, editor. Health Insurance Portability and Accountability Act of 1996. New York: The Quick Reference Archive of Business Law; 1996."},{"key":"1811_CR19","unstructured":"YCN Gynaecology Network Site Specific Group (NSSG). Guidelines for the management of gynaecological cancers: Yorkshire Cancer Network; 2015."},{"key":"1811_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejogrb.2007.02.029","volume":"137","author":"O Ortashi","year":"2008","unstructured":"Ortashi O, Jain S, Emannuel O, Henry R, Wood A, Evans J. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol. 2008;137:232\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"1811_CR21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/IGC.0b013e3182571490","volume":"22","author":"MH McComiskey","year":"2012","unstructured":"McComiskey MH, McCluggage WG, Grey A, Harley I, Dobbs S, Nagar HA. Diagnostic accuracy of magnetic resonance imaging in endometrial cancer. Int J Gynecol Cancer. 2012;22:1020\u20135.","journal-title":"Int J Gynecol Cancer."},{"key":"1811_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/00016340903141135","volume":"88","author":"DS Suh","year":"2009","unstructured":"Suh DS, Kim JK, Kim KR, Kim DY, Kim JH, Kim YM, et al. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma. Acta Obstet Gynecol Scand. 2009;88:990\u20133.","journal-title":"Acta Obstet Gynecol Scand."},{"key":"1811_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ygyno.2005.12.028","volume":"102","author":"Y Nakao","year":"2006","unstructured":"Nakao Y, Yokoyama M, Hara K, Koyamatsu Y, Yasunaga M, Araki Y, et al. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol. 2006;102:343\u20137.","journal-title":"Gynecol Oncol."},{"key":"1811_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3109\/00016349509021206","volume":"74","author":"W Minderhoud-Bassie","year":"1995","unstructured":"Minderhoud-Bassie W, Treurniet FE, Koops W, Chadha-Ajwani S, Hage JC, Huikeshoven FJ. Magnetic resonance imaging (MRI) in endometrial carcinoma; preoperative estimation of depth of myometrial invasion. Acta Obstet Gynecol Scand. 1995;74:827\u201331.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"4","key":"1811_CR25","first-page":"400","volume":"68","author":"O Ofinran","year":"2016","unstructured":"Ofinran O, Balega J. The value of magnetic resonance imaging in investigating complex atypical hyperplasia of the endometrium. Minerva Ginecol. 2016;68(4):400\u20134.","journal-title":"Minerva Ginecol."},{"key":"1811_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3348\/kjr.2004.5.1.39","volume":"5","author":"JA Ryu","year":"2004","unstructured":"Ryu JA, Kim B, Lee J, Kim S, Lee SH. Comparison of transvaginal ultrasonography with hysterosonography as a screening method in patients with abnormal uterine bleeding. Korean J Radiol. 2004;5:39\u201346.","journal-title":"Korean J Radiol."},{"key":"1811_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4103\/0300-1652.170390","volume":"56","author":"B Shokouhi","year":"2015","unstructured":"Shokouhi B. Role of transvaginal ultrasonography in diagnosing endometrial hyperplasia in pre- and post-menopause women. Niger Med J. 2015;56:353\u20136.","journal-title":"Niger Med J"},{"key":"1811_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/AOG.0b013e3181e3e7e8","volume":"116","author":"A Timmermans","year":"2010","unstructured":"Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol. 2010;116:160\u20137.","journal-title":"Obstet Gynecol."},{"key":"1811_CR29","first-page":"663","volume":"99","author":"A Tabor","year":"2002","unstructured":"Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol. 2002;99:663\u201370.","journal-title":"Obstet Gynecol."},{"key":"1811_CR30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1034\/j.1600-0412.2001.810902.x","volume":"81","author":"JK Gupta","year":"2002","unstructured":"Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002;81:799\u2013816.","journal-title":"Acta Obstet Gynecol Scand."},{"key":"1811_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5468\/ogs.2016.59.3.192","volume":"59","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Kim JJ, Kim SM. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women. Obstet Gynecol Sci. 2016;59:192\u2013200.","journal-title":"Obstet Gynecol Sci."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-1811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-020-1811-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-1811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:41:09Z","timestamp":1612834869000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-1811-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-1811-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Statement of ethical approval was included in the \u201cMaterials and methods\u201d section.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}